Furthermore, CX3CL1 levels in M1 and M2 culture media were increased by 7.43-fold and 4.01-fold respectively in the BBB model with PBMCs from mild AD patients versus control patients (Fig 3). The gene discussed is CX3CL1; the disease is Alzheimer disease.